Investing
Merger Monday is back with a bang. Despite economic uncertainty, high interest rates, recent bank turmoil and the risk of a recession, there’s been...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
Investing
U.S. natural-gas supplies in storage marked their biggest weekly decline in nearly three years — but that wasn’t enough to rally prices for the...
Investing
Oil futures rose Thursday to settle at their highest prices since late November after government data showed larger-than-anticipated drops in U.S. crude inventories and...
Investing
Oil prices gave up early losses to finish higher on Friday — with production outages in the U.S., strong economic data and concerns about...
Investing
Investors and analysts are consumed with fear that online advertising is melting down. The outlook is not as bad as it seems. Let me...
Investing
Stocks closed higher Monday, reversing earlier losses, with debt-ceiling talks this week a focus for Wall Street. These stocks made moves Monday: Oneok (OKE) reached an...
Investing
Late Friday, a panel of experts voted to recommend speedy approval of Sarepta Therapeutics ‘ gene therapy for muscular dystrophy—sending the stock soaring. Stock...
Investing
World Wrestling Entertainment Inc. WWE, +1.92% announced Monday agreements with certain investors to exchange 6.9 million newly issued shares of common stock and $3.9...
Investing
The stocks of H&R Block Inc. HRB, -2.84% and TurboTax parent Intuit Inc. INTU, -0.33% fell premarket Monday, ahead of the release this week...
Investing
Shares of Fisker Inc. FSR, +3.45% fell 1.0% in premarket trading Monday, after the electric vehicle maker said it was ramping up production to...
Investing
Sarepta Therapeutics Inc.’s stock SRPT, +30.73% soared 30% premarket Monday, after a U.S. Food and Drug Administration panel voted 8-6 in favor of accelerated...
Investing
Raymond James on Monday upgraded financial firm The Charles Schwab Corp. SCHW, +5.46% to outperform from market perform, with a price target of $63...
Investing
Recap from March’s Picks On a price return basis, the Dividend Growth Stocks Model Portfolio (-0.5%) underperformed the S&P 500 (+1.2%) by 1.7% from...
